2010, Number 594
<< Back Next >>
Rev Med Cos Cen 2010; 67 (594)
Causas de muerte en pacientes con lupus eritematoso sistémico (LES) en el Hospital México de 1989 a 2004
Vargas MJ, Moreira VC, Núñez DK, Núñez DM
Language: Spanish
References: 21
Page: 337-343
PDF size: 596.41 Kb.
ABSTRACT
Aim and objective: To determine the major causes of death among the systemic erythematosus lupus patients who died in Hospital Mexico.
Methods: A list of autopsies reports with clinical diagnosis of systemic lupus erythematosus seen in Hospital Mexico from 1989 to the year 2004 was supplied by the Pathology Service database. The information was collected and analyzed.
Results: 54 patients were studied with a female to male ratio of 6,7: 1. The mean age at presentation was 28, 3 years (range 6 – 64 years) and the mean age at death was 33,3 years (range 14 – 68 years). Infectious causes were the most common cause of death, occurring both early and late periods, in 28 (52,83%) patients, followed by pulmonary causes in 7 (13,21%) and renal chronic failure and gastrointestinal causes in 5 (9,43%) patients each.
Conclusions: Infections were the most common cause of death and these deaths occurred throughout the course of illness.
REFERENCES
Abello, M. Pronóstico en lupus eritematoso sistémico. Revista Colombiana de Reumatología.www.encolombia.com/medicina/reumatologia/reuma82-10-pronostico.htm (accesada el 06/01/ 2005)
Abu-Shakra M, Urowitz M, Gladman D, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center I. Predictor Variables for mortality. J Rheumatology 1995; 22:1259-1264.
Abu-Shakra M, Urowitz M, Gladman D, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II Predictor Variables for mortality. J Rheumatology 1995; 22:1265-1270.
Boumpas D, Austin H, Fessler B, Balow J, Klippel J, Lockshin M. Systemic Lupus Erythematosus: Emerging concepts. Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary and Hematologic Disease. Annals of Internal Medicine 1995; 122: 940- 950.
Boumpas D, Fessler B, Austin H, Balow J, Klippel J, Lockshin M. Systemic Lupus Erythematosus: Emerging concepts. Part 2: Dermatologic and Joint disease, the anti phospholipids antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Annals of Internal Medicine 1995; 123: 42-53.
Ginzler E, Diamond H, Weiner M, Schlesinger M, Fries J, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus. I Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601-611.
Gordon C. Long - term complications systemic lupus erythematosus. Rheumatology 2002; 41: 1095-1100.
Iriya S, Capelozzi V, Calich I, Martins M, Lichtenstein A. Causes of death in patients with systemic lupus erythematosus in Sao Paolo, Brazil: A study of 113 autopsies. Arch Intern Med 2001; 161: 1557-1558.
McLaughlin J, Bombardier C, Farewell V, Gladman D, Urowitz M. Kidney biopsy in systemic lupus erythematosus. III Survival Analysis Controlling for Clinical and Laboratory Variables. Arthritis Rheum 1994; 04: 559-567.
Mok C, Lee K, Ho C, Lau C, Wong R. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology 2000; 39: 399-406.
Petri M, Perez-Gutthann S, Longenecker J, Hochberg M. Morbidity of systemic lupus erythematosus: Role of Race and Socioeconomic Status. Am J Med 1991; 91:345-353.
Pistiner M, Wallace D, Nessim S, Metzger A, Klinenberg J. Lupus Erythematosus in the 1980s: A survey of 570 Patients. Semin Arthritis Rheum 1991; 21: 55-64
Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus: negative impact of increasing age onset, black race and thrombocytopenia as well as causes of death. Arthritis Rheum 1990; 33:37-48.
Rosner S, Ginzler E, Diamond H, Weiner M, Schlesinger M, Fries J, et al. A multicenter study of outcome in systemic lupus erythematosus. Causes of death. Arthritis Rheum 1982; 85: 612-617.
Steinberg A, Gourley M, Klinman D, Tsokos G, Scott D, Krieg. Systemic Lupus Erythematosus. Annals of Internal Medicine 1991; 115: 548-559.
Studenski S, Allen N, Caldwell D, Rice J, Polisson R. Survival in Systemic Lupus Erythematosus. A Multivariate Analysis of Demographic Factors. Arthritis Rheum 1987; 30: 1326-1332.
Uramoto K, Michet C, Thumboo J, Sunku J, O´Fallon M, Gabriel S. Trends in the incidence and mortality of Systemic Lupus Erythematosus 1950 – 1992.Arthritis Rheum 1999; 42: 46-50.
Ward M. Hospital Experience and Mortality in patients with Systemic Lupus Erythematosus. Arthritis Rheum 1999; 42: 891-898.
Ward M. Premature Morbidity from Cardiovascular and Cerebrovascular Diseases in women With Systemic Lupus Erythematosus. Arthritis Rheum 1999; 42: 338-346.
Ward M, Pyun E, Studenski S. Causes of death in Systemic Lupus Erythematosus. Long Term followup of an inception cohrt. Arthritis Rheum 1995; 10: 1492-1499.
Ward M, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156:1337-1344.